Across TCGA pan-cancer cohorts, SSXP4 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated SSXP4 data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher SSXP4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SSXP4 expression acts as an unfavorable survival marker.
SKCM, UVM, and THCA are the cancer types where SSXP4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.